ask="3.43"
ask_size="1000"
average_daily_volume="57816"
bid="2.80"
bid_size="500"
book_value="1.19"
change="-0.06"
change_from_200_day_moving_average="-1.11"
change_from_50_day_moving_average="-0.45"
change_from_52_week_high="-3.38"
change_From_52_week_low="0.18"
change_in_percent="-1.90%"
close="3.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.81"
ex_dividend_date="N/A"
float_shares="5652000"
high="3.25"
high_52_weeks="6.47"
last_trade_date="1/19/2017"
last_trade_price="3.10"
last_trade_size="300"
last_trade_time="3:57pm"
low="3.06"
low_52_weeks="2.92"
market_capitalization="19.52M"
moving_average_200_day="4.21"
moving_average_50_day="3.55"
name="MabVax Therapeutics Holdings
I"
notes="N/A"
one_year_target_price="18.00"
open="3.20"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-26.36%"
percent_change_from_50_day_moving_average="-12.69%"
percent_change_from_52_week_high="-52.12%"
percent_change_from_52_week_low="+6.16%"
previous_close="3.16"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.65"
price_per_sales="21.97"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="5.29"
stock_exchange="NCM"
symbol="MBVX"
volume="14367"
weeks_range_52="2.92 - 6.47"
